1.74 USD
↗ 0.01 (0.29%)PRE MARKET (AS OF 04:01 AM EDT)
GRI Bio, Inc. Common Stock
GRINASDAQ • USD
Market: OPEN
GRI Bio, Inc. Common Stock (GRI) trades at $1.74 per share. Technicals currently rate "Neutral" while our fundamental analysis reads "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation side, GRI appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Aug 18, 2026.
Open?$1.74
High?$1.74
Low?$1.74
Prev. Close?$1.73
Volume?1
Avg. Volume?277.4K
VWAP?$1.74
Rel. Volume?0.00x
Bid / Ask
Bid?$1.48 × 100
Ask?$1.98 × 100
Spread?$0.50
Midpoint?$1.73
Valuation & Ratios
Market Cap?3.0M
Shares Out?1.8M
Float?1.7M
Float %?97.9%
P/E Ratio?N/A
P/B Ratio?0.29
EPS?-$5.45
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.
Address
2223 AVENIDA DE LA PLAYA
LA JOLLA, CA 92037
Phone: (619) 400-1171
LA JOLLA, CA 92037
Phone: (619) 400-1171
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?65
Short Sent.?54
Piotroski F-Score?0/9Weak
Altman Z-Score?-6.88Distress
Confidence?49%Low
Short InterestElevated
Short % of Float?6.35%Elevated
Short Interest?110.0K
Days to Cover?4.5
Free Float1.7M
Avg Daily Volume24.7K
Settlement Date2026-07-31
Financial Health
Current Ratio?10.30Strong
Quick Ratio?10.30Strong
Cash Ratio?9.95Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.29CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?0.8CHEAP▾
Peers100
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-94.0%WEAK▾
S&P3
ROA?-84.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-10418000
Enterprise Value?$-7918867
Fundamentals ratios updated end of day